Audit 354167

FY End
2024-09-30
Total Expended
$69.73M
Findings
0
Programs
13
Year: 2024 Accepted: 2025-04-22
Auditor: Cbiz CPAS PC

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $41.10M Yes 0
93.967 Centers for Disease Control and Prevention Collaboration with Academia to Strengthen Public Health $21.62M - 0
93.462 Strengthening the Technical Advancement & Readiness of Public Health Via Health Information Exchange Program $1.76M - 0
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $1.42M - 0
93.078 Strengthening Emergency Care Delivery in the United States Healthcare System Through Health Information and Promotion $1.12M - 0
93.011 National Organizations for State and Local Officials $1.09M Yes 0
93.103 Food and Drug Administration Research $393,862 - 0
15.875 Economic, Social, and Political Development of the Territories $337,795 - 0
93.322 Cdc Partnership: Strengthening Public Health Laboratories $119,172 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $101,609 - 0
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $95,751 - 0
66.510 Surveys, Studies, Investigations and Special Purpose Grants Within the Office of Research and Development $93,725 - 0
93.334 The Healthy Brain Initiative: Technical Assistance to Implement Public Health Actions Related to Cognitive Health, Cognitive Impairment, and Caregiving at the State and Local Levels $56,419 - 0

Contacts

Name Title Type
Q4PDHB7J12R8 Jerrod McFarland Auditee
2023719090 Douglas Boedeker Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: ASTHO has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal grant activity of Association of State and Territorial Health Officials’ (“ASTHO”) under programs of the federal government for the year ended September 30, 2024. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of ASTHO, it is not intended to, and does not, present the financial position, changes in net assets, or cash flows of ASTHO.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: ASTHO has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Title: Indirect Cost Rate Accounting Policies: Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: ASTHO has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. ASTHO has not elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.